You can buy or sell Exelixis and other stocks, options, ETFs, and crypto commission-free!
Exelixis, Inc. Common Stock, also called Exelixis, is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. Read More It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA. The listed name for EXEL is Exelixis, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Oct 29, After Hours